Dogwood Therapeutics (DWTX) to Release Quarterly Earnings on Wednesday

Dogwood Therapeutics (NASDAQ:DWTX) will likely be issuing its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($1.36) per share for the quarter.

Dogwood Therapeutics Stock Performance

Shares of NASDAQ DWTX opened at $5.38 on Monday. Dogwood Therapeutics has a 12 month low of $1.62 and a 12 month high of $29.28. The stock has a market capitalization of $7.17 million, a P/E ratio of -0.82 and a beta of 1.92. The company’s fifty day moving average is $5.83.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.